Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Revenue | 4.04bn | 3.45bn | 3.28bn | 3.03bn | 2.71bn | 2.63bn |
| Cost of revenue | 1.99bn | 1.69bn | 1.62bn | 1.50bn | 1.37bn | 1.39bn |
| Research and development | 398m | 355m | 351m | 306m | 289m | 303m |
| Selling, general and administrative | 432m | 400m | 388m | 332m | 315m | 494m |
| Operating expenses | 3.89bn | 3.19bn | 3.12bn | 2.88bn | 2.60bn | 2.83bn |
| Operating income | 151m | 258m | 163m | 155m | 107m | −201m |
| Pre-tax income | 191m | 248m | 271m | 198m | 155m | −157m |
| Income tax | 8m | 5m | −13m | 6m | −6m | 1m |
| Net income | 184m | 244m | 285m | 193m | 162m | −157m |
| Earnings per share | 0.42 | 0.57 | 0.67 | 0.46 | 0.39 | −0.38 |
| Earnings per share, diluted | 0.42 | 0.55 | 0.65 | 0.44 | 0.38 | −0.38 |
| Weighted average shares | 435m | 429m | 425m | 421m | 413m | 410m |
| Weighted average shares, diluted | 442m | 442m | 438m | 436m | 428m | 410m |
| Metric | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 4.58bn | 4.38bn | 3.28bn | 3.91bn | 4.50bn | 4.02bn | 3.66bn | 3.43bn |
| Receivables | 1.03bn | 1.11bn | 894m |
| Metric | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 594m | — | — | 635m | — | — |
| Depreciation and amortisation | 269m | 169m | 159m | 152m |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)
| 840m |
| 782m |
| 732m |
| 622m |
| 585m |
| Current assets | 8.59bn | 8.64bn | 10.49bn | 9.74bn | 7.85bn | 7.39bn | 6.76bn | 6.62bn |
| Goodwill | 5.50bn | 5.52bn | 3.57bn | 3.53bn | 2.41bn | 2.32bn | 2.46bn | 2.37bn |
| Total assets | 19.71bn | 19.66bn | 17.97bn | 16.95bn | 13.57bn | 12.85bn | 12.28bn | 11.84bn |
| Current liabilities | 6.03bn | 6.15bn | 5.13bn | 4.70bn | 4.58bn | 4.44bn | 4.09bn | 4.03bn |
| Total liabilities | 9.50bn | 9.61bn | 8.46bn | 8.02bn | 5.18bn | 5.04bn | 4.70bn | 4.67bn |
| Equity | 10.20bn | 10.03bn | 9.50bn | 8.92bn | 8.39bn | 7.80bn | 7.57bn | 7.16bn |
| 138m |
| 140m |
| Share-based compensation | 231m | — | — | 235m | — | — |
| Capital expenditure | 57m | — | — | 74m | — | — |
| Investing cash flow | −98m | — | — | −160m | — | — |
| Share buybacks | 162m | — | — | 0 | — | — |
| Financing cash flow | −173m | — | — | 3m | — | — |